ZTS:NYSE
Zoetis Inc
$82.96
arrow_upward
+0.47%(+0.39) 1D
$82.60
arrow_downward
-0.43% (-0.36)bedtimeAfter hours
Closed: Nov 12, 4:03:39 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZTS...
Open
$82.69
High
$83.84
Low
$82.48
Mkt. cap
33.71B
Avg. vol.
4.53M
Volume
4.39M
Dividend
2.56%
Quarterly dividend
$0.53
Ex-dividend date
Oct 30, 2026
P/E ratio
14.09
52-wk high
$132.49
52-wk low
$68.77
EPS
$5.89
Beta
0.67
Shares outstanding
406.32M
No. of employees
14K
Open
$82.69
High
$83.84
Low
$82.48
Mkt. cap
33.71B
Avg. vol.
4.53M
Volume
4.39M
Dividend
2.56%
Quarterly dividend
$0.53
Ex-dividend date
Oct 30, 2026
P/E ratio
14.09
52-wk high
$132.49
52-wk low
$68.77
EPS
$5.89
Beta
0.67
Shares outstanding
406.32M
No. of employees
14K
News stories
From web sources and news partners
Zacks
·
17 hours ago
Zoetis' Cytopoint Plus Gets USDA License for 75-Day Canine Itch Relief
Kalkine
·
19 hours ago
What Does the USDA License for Cytopoint Plus Mean for Zoetis (NYSE:ZTS) and Dog Owners?
Yahoo Finance
·
1 day ago
Zoetis Receives USDA License for Cytopoint Plus™: The First and Only Long-Acting Monoclonal Antibody Providing 75 Days of Allergic Itch Relief in Dogs with Allergic Dermatitis
Barchart.com
·
1 day ago
What Are Wall Street Analysts' Target Price for Zoetis Stock?
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
About Zoetis Inc
CEOKristin C. Peck
Employees14.5K
Founded1952
HeadquartersParsippany-Troy Hills, New Jersey, United States
SectorHealth Care
IndustryPharmaceutical industry
Websitezoetis.com